Favorable outcomes of <i>DDX41</i>‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide-Reference-Cited by-同舟云学术

Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide

Author:

Tiong Ing S.¹²³^ORCID,Stevenson William S.⁴⁵,Wall Meaghan³⁶,Yap Yan Zhuang¹,Seymour John F.¹⁷⁸,Kenealy Melita³⁹,Blombery Piers¹⁷⁸^ORCID,

Affiliation:

1. Peter MacCallum Cancer Centre Melbourne Victoria Australia

2. The Alfred Hospital Melbourne Victoria Australia

3. Monash University Melbourne Victoria Australia

4. Royal North Shore Hospital St Leonards New South Wales Australia

5. Northern Clinical School, University of Sydney Sydney New South Wales Australia

6. Victorian Clinical Genetics Services, Murdoch Children's Research Institute Melbourne Victoria Australia

7. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Victoria Australia

8. Royal Melbourne Hospital Melbourne Victoria Australia

9. Cabrini Health Melbourne Victoria Australia

Funder

Snowdome Foundation

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

Reference15 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献